Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu

Antonin Borovicka

Jiri Krepelka

Karel Rezabek

Antonin Cerny

Bohumil Sevcik

Milan Pesak

Josef Kral

Josef Picha

Maria Fruhaufova

Josef Stuchlik

Jana Strakova

Petr Bilek

Dagmar Picmausova

This invention relates to a method for the treatment of endometritis (chronic and/or acute puerperal inflammations) in mammalian females comprising the administration of 1-(8-alpha-ergolinyl)-3,3-diethylurea derivatives of Formula I ##STR1## in which R.sup.1 represents an alkyl group containing 1 to 3 carbon atoms, R.sup.2 represents a hydrogen atom or an alkyl group containing 1 to 3 carbon atoms, and X represents a hydrogen atom or a double bond between the carbon atoms at positions 9 and 10. The compound according to Formula I, or a pharmaceutically acceptable acid addition salt thereof, is the physiologically active component of the therapeutic composition and method. The compound may be combined with a pharmaceutically acceptable diluent, vehicle, excipient, auxiliary, or carrier. The invention is particularly advantageous in veterinary medicine, when applied to the treatment of farm animals, such a cows.

Method for treatment of endometritis in mammalian females

Growing community of inventors

Davle, Czechoslovakia

Antonin Borovicka